Is Omega Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Omega Therapeutics Inc (OMGAQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Omega Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Omega Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Omega Therapeutics Inc?

Muslim investors may consider investing in Omega Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Omega Therapeutics Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Omega Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Omega Therapeutics Inc updated?

The Shariah compliance status of Omega Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Omega Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Omega Therapeutics Inc?

You can check the latest Shariah compliance status of Omega Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Omega Therapeutics Inc. Stock Analysis OMGAQ

United States Health Care Nano Cap

Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 93 full-time employees. The company went IPO on 2021-07-30. The Company’s OMEGA platform has enabled it to identify and validate various DNA-sequence-based epigenomic, zip codes, associated with individual regulatory elements within Insulated Genomic Domains (IGDs). The firm designs and engineers its mRNA therapeutics, called epigenomic controllers, or ECs, to target EpiZips for precision epigenomic control. Its pipeline consists of programs that span oncology, regenerative medicine, and multigenic diseases including immunologic and cardiometabolic conditions. The Company’s precision epigenomic control delivered by the OMEGA platform has therapeutic applicability and transformational potential, spanning across oncology, multigenic diseases including immunologic and cardiometabolic conditions, and regenerative medicine.

Key Statistics of Omega Therapeutics Inc (OMGAQ)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.01

Today's Open

$0.01

Volume

23.87K

P/E Ratio (TTM)

52 Week Range

$0.00$0.96

Market Cap

166.10K

Avg. Volume

89.13K

Dividend Yield

Financial Metrics & Statements of Omega Therapeutics Inc (OMGAQ)

FAQ's for Omega Therapeutics Inc (OMGAQ)

According to Musaffa’s Shariah screening methodology, Omega Therapeutics Inc (OMGAQ) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.